Benzinga - Tue, 30 Mar 2021 16:15:22 -0400
Benzinga - Wed, 10 Mar 2021 06:19:51 -0400
Benzinga - Tue, 09 Mar 2021 13:19:34 -0400
Benzinga - Tue, 02 Mar 2021 11:02:34 -0400
Benzinga - Mon, 01 Mar 2021 11:14:41 -0400
Benzinga - Mon, 01 Mar 2021 05:56:51 -0400
load more
Angion Biomedica Corp is a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Its product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic that is evaluating in multiple acute organ injuries and related indications, including acute kidney injury (AKI) and injuries to other major organs, such as the lungs, central nervous system (CNS) and heart; acute lung injury (ALI), with primary focus on acute respiratory distress syndrome (ARDS), and acute CNS injuries. It is advancing multiple programs for the treatment of fibrotic diseases, leading with ANG-3070, a tyrosine kinase inhibitor (TKI), and inhibitor of rho kinase 2 (ROCK2).

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-08
REV
Q4 2020Est.ActualSurprise
EPS-1.300-1.900 -0.6000
REV1.900M459.000K-1.441M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ANGNAngion Biomedica-6.48%

Angion Biomedica Company Questions & Answers

Q

How do I buy Angion Biomedica (ANGN) stock?

A

You can purchase shares of Angion Biomedica (NASDAQ: ANGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Angion Biomedica's (ANGN) main competitors?

A

There are no as such competitors for Angion Biomedica.

Q

What is the target price for Angion Biomedica?

A

The latest price target for Angion Biomedica (NASDAQ: ANGN) was reported by Cowen & Co. on 2021-03-02. The analyst firm set a price target for 0.00 expecting ANGN to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q

How much is Angion Biomedica (ANGN) stock ?

A

The stock price for Angion Biomedica (NASDAQ: ANGN) is $15.13 last updated Today at 8:00:02 PM.

Q

When is the next Angion Biomedica (ANGN) dividend?

A

There are no upcoming dividends for Angion Biomedica.

Q

When is Angion Biomedica (NASDAQ:ANGN) reporting earnings?

A
Angion Biomedica’s Q1 earnings are confirmed after-market from now on June 8, 2021.
Q

When is the upcoming split for ANGN?

A

There is no upcoming split for Angion Biomedica.